RxDoctor Payments Data

Philip Stella

Medical Oncology · Ypsilanti, MINPI 1194725671

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,722 of the $1,829 with a category attached, or 94.2%. F. Hoffmann-la Roche AG accounts for 94.2% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for medical oncology clinicians in MI, where the typical reported total is $1,832.

$1,829in general payments, 2019–2025

Across 4 payments — averaging $457.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • F. Hoffmann-la Roche AG$2K
  • Foundation Medicine, Inc.$56
  • Amgen$51
$1,246,979in research payments, 2019–2025

Across 134 payments — averaging $9305.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$881K
  • F. Hoffmann-la Roche AG$128K
  • Eli Lilly$85K
  • Genentech, Inc.$62K
  • E.r. Squibb & Sons, L.L.C.$39K
  • Pfizer$31K
  • plus $20K from 3 others

What the payments were for

  • Speaking & faculty fees$1,72294%
  • Food & beverage$1076%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,829 in reported general payments places this provider in the 45th percentile of 170 medical oncology providers in Michigan.

See all medical oncology providers in Michigan

Other medical oncology in Ypsilanti

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →